- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Angiogenesis: Pericytes and Maturation Are Not to Be Ignored
Authors
Keywords
-
Journal
Journal of Oncology
Volume 2012, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2011-10-11
DOI
10.1155/2012/261750
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating Endothelial Cells and Circulating Progenitor Cells in Breast Cancer: Relationship to Endothelial Damage/Dysfunction/ Apoptosis, Clinicopathologic Factors, and the Nottingham Prognostic Index
- (2015) Patrick K.Y. Goon et al. NEOPLASIA
- The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses’ Health Study
- (2011) Ying Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases
- (2011) A M Jubb et al. BRITISH JOURNAL OF CANCER
- Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
- (2011) P Österlund et al. BRITISH JOURNAL OF CANCER
- VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
- (2011) W.-K. You et al. CANCER RESEARCH
- Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer
- (2011) A. M. Jubb et al. CLINICAL CANCER RESEARCH
- Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance
- (2011) Rabab A A Mohammed et al. MODERN PATHOLOGY
- Pericytes and vessel maturation during tumor angiogenesis and metastasis
- (2010) Ahmad Raza et al. AMERICAN JOURNAL OF HEMATOLOGY
- Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A Meta-Analysis
- (2010) V. Ranpura et al. AMERICAN JOURNAL OF HYPERTENSION
- Delta-like ligand 4-Notch signaling regulates bone marrow-derived pericyte/vascular smooth muscle cell formation
- (2010) K. S. Stewart et al. BLOOD
- Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials
- (2010) A. Valachis et al. BREAST CANCER RESEARCH AND TREATMENT
- Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up
- (2010) Lisa Rydén et al. BREAST CANCER RESEARCH AND TREATMENT
- Human epidermal growth factor receptor-2-positive breast cancer: current management of early, advanced, and recurrent disease
- (2010) Rena Callahan et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- Clinical Course of Advanced Non–Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4599
- (2010) Suzanne E. Dahlberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Estradiol-dependent regulation of angiopoietin expression in breast cancer cells
- (2010) Rania Harfouche et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Biomarkers to predict the clinical efficacy of bevacizumab in cancer
- (2010) Adrian M Jubb et al. LANCET ONCOLOGY
- Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1
- (2010) Kakali Dhar et al. Molecular Cancer
- Interactions with Fibroblasts Are Distinct in Basal-Like and Luminal Breast Cancers
- (2010) J. T. Camp et al. MOLECULAR CANCER RESEARCH
- A Mutated Soluble Neuropilin-2 B Domain Antagonizes Vascular Endothelial Growth Factor Bioactivity and Inhibits Tumor Progression
- (2010) E. Geretti et al. MOLECULAR CANCER RESEARCH
- BRCA mutations in the management of breast cancer: the state of the art
- (2010) Steven A. Narod Nature Reviews Clinical Oncology
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Significance of Stromal Platelet-Derived Growth Factor β-Receptor Expression in Human Breast Cancer
- (2009) Janna Paulsson et al. AMERICAN JOURNAL OF PATHOLOGY
- Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1
- (2009) Sébastien Toffoli et al. ANGIOGENESIS
- Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma
- (2009) P. Bono et al. ANNALS OF ONCOLOGY
- A compact VEGF signature associated with distant metastases and poor outcomes
- (2009) Zhiyuan Hu et al. BMC Medicine
- BRCA1 tumours correlate with a HIF-1α phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression
- (2009) M Yan et al. BRITISH JOURNAL OF CANCER
- PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
- (2009) Yongping Crawford et al. CANCER CELL
- Overexpression of Platelet-Derived Growth Factor-BB Increases Tumor Pericyte Content via Stromal-Derived Factor-1 /CXCR4 Axis
- (2009) N. Song et al. CANCER RESEARCH
- Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1 , CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer
- (2009) L. Xu et al. CANCER RESEARCH
- Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast
- (2009) Kentaro Tamaki et al. CANCER SCIENCE
- VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2
- (2009) Z Zhang et al. CELL DEATH AND DIFFERENTIATION
- Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model
- (2009) Juan JuanYin et al. CLINICAL & EXPERIMENTAL METASTASIS
- Quantifying Antivascular Effects of Monoclonal Antibodies to Vascular Endothelial Growth Factor: Insights from Imaging
- (2009) J. P.B. O'Connor et al. CLINICAL CANCER RESEARCH
- Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab
- (2009) A. Calleri et al. CLINICAL CANCER RESEARCH
- Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature
- (2009) E.-M. Hedlund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast
- (2009) M. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The endothelial antigen ESAM marks primitive hematopoietic progenitors throughout life in mice
- (2008) T. Yokota et al. BLOOD
- Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment
- (2008) M J Slade et al. BRITISH JOURNAL OF CANCER
- Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100
- (2008) Bryan P. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Adrenomedullin signaling is necessary for murine lymphatic vascular development
- (2007) Kimberly L. Fritz-Six et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now